Drugs for MRSA with Reduced Susceptibility to Vancomycin

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2009年 / 51卷 / 1311期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
    Neoh H.-M.
    Hori S.
    Komatsu M.
    Oguri T.
    Takeuchi F.
    Cui L.
    Hiramatsu K.
    [J]. Annals of Clinical Microbiology and Antimicrobials, 6 (1)
  • [2] Reduced Daptomycin Susceptibility in Clinical MRSA Isolates Showing Vancomycin MIC Creep Phenomenon
    Kulkarni, Ketaki Vyankatesh
    Pathak, Niranjan
    Kulkarni, Sandhya Sadanand
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (07)
  • [3] EVALUATION OF REDUCED SUSCEPTIBILITY TO VANCOMYCIN AMONG MRSA STRAINS ISOLATED FROM CLINICAL SPECIMENS
    Aktas, Elif
    Mengeloglu, Firat Zafer
    Kulah, Canan
    Comert, Fusun Begendik
    [J]. MIKROBIYOLOJI BULTENI, 2010, 44 (02): : 339 - 341
  • [4] Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections
    Canty, Ethan
    Carnahan, Benjamin
    Curley, Tara
    Anususinha, Emily
    Hamdy, Rana F.
    Ericson, Jessica E.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (05) : 429 - 433
  • [5] Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin
    Grabs, AJ
    Lor, RSA
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2002, 176 (11) : 563 - 563
  • [6] Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin
    Ward, PB
    Johnson, PDR
    Grabsch, EA
    Mayall, BC
    Grayson, ML
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (09) : 480 - +
  • [7] Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin
    Lodise, T. P.
    Drusano, G. L.
    Lazariu, V.
    El-Fawal, N.
    Evans, A.
    Graffunder, E.
    Stellrecht, K.
    Mendes, R. E.
    Jones, R. N.
    Cosler, L.
    McNutt, L. A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2547 - 2555
  • [8] Staphylococcus aureus with reduced susceptibility to vancomycin
    Cosgrove, SE
    Carroll, KC
    Perl, TM
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 539 - 545
  • [9] Reduced Susceptibility to Vancomycin in Staphylococcus aureus
    Mimica, Marcelo J.
    [J]. EMERGING INFECTIOUS DISEASES, 2011, 17 (11) : 2083 - 2084
  • [10] Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72
    Baek, Jin Yang
    Chung, Doo Ryeon
    Ko, Kwan Soo
    Kim, So Hyun
    Yang, Soo-Jin
    Kang, Cheol-In
    Peck, Kyong Ran
    Song, Jae-Hoon
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (09) : 2454 - 2460
12345